US1924461023 - Common Stock
COGNIZANT TECH SOLUTIONS-A
NASDAQ:CTSH (11/22/2024, 8:00:00 PM)
After market: 78.99 -0.55 (-0.69%)79.54
+0.68 (+0.86%)
Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. The company is headquartered in Teaneck, New Jersey and currently employs 340,100 full-time employees. The firm operates through four segments: Financial Services (FS), Health Sciences (HS), Products and Resources (P&R), and Communications, Media and Technology (CMT). The FS segment includes banking, capital markets, payments and insurance companies. Its HS segment consists of healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech and medical device companies. Its P&R segment includes manufacturers, automakers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services. Its CMT segment includes global communications, media and entertainment, education, information services and technology companies. Its services include digital services and solutions, consulting, application development, systems integration, quality engineering and assurance, application maintenance, and infrastructure and security.
COGNIZANT TECH SOLUTIONS-A
300 Frank W. Burr Blvd., Ste. 36, 6 Fl.
Teaneck NEW JERSEY 07666
P: 12018010233
CEO: Brian Humphries
Employees: 340100
Website: https://www.cognizant.com/
/PRNewswire/ -- Cognizant (NASDAQ: CTSH) announced today the continuation of its relationship with Savvas Learning Company with the aim to ensure that IT...
/PRNewswire/ -- Cognizant (NASDAQ: CTSH) and IBM announced the debut of a new FinOps1 Center of Excellence (CoE), built on IBM's leading FinOps software and...
Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency1, the high end of our guidance ranges Operating margin of 14.6%,...
/PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced it has reached more than 275,000 people via its global skilling initiative, Synapse, which launched...
/PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today a new agreement with Alnylam Pharmaceuticals, Inc., a leading biopharmaceutical company and the...
Here you can normally see the latest stock twits on CTSH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: